Gastrointestinal Cancer Clinical Trial
The COMplementary hand-foot Massage to Improve experience of ilneSs trial (COMMIS trial) is
a prospective, randomized trial and executed at a Western referral Centre: Zuyderland
Medical Centre located Sittard-Geleen, The Netherlands concerning patients who underwent
surgery for gastrointestinal malignancy. During 5 consecutive days, the intervention group
received postoperatively hand-foot massage administered by trained volunteers.
The aim of this study is to investigate the effect of complementary therapies concerning
quality of life, pain, nausea, fatigue, sleeping problems, mood and stress in patients who
underwent an operation as a result of gastrointestinal malignancy (stomach or colorectal).
The COMplementary hand-foot Massage to Improve experience of ilneSs trial (COMMIS trial) is
a prospective, randomized trial and executed at a Western referral Centre: Zuyderland
Medical Centre located Sittard-Geleen, The Netherlands.
The aim of this study is to investigate the effect of complementary therapies concerning
quality of life, pain, nausea, fatigue, sleeping problems, mood and stress in patients who
underwent an operation as a result of gastrointestinal malignancy (stomach or colorectal).
Patients had to be >18 years of age. Exclusion criteria were patients who were not able to
undergo massage, not able to sign informed consent or speaking the native language, deaf
patients and patients having a hand- or foot disorder.
Primary outcome measure is quality of life, including psychological state, level of
functioning in daily life and pain. Secondary outcome measures are patient satisfaction
about the received hospital care and the need for complementary medicine.
Recruitment takes place during the second preoperative appointment at the clinic, where
eligible patients receive oral and written information about the study. One week after this
conversation, patients are asked if they are interested to participate. If so, informed
consent is obtained and remaining questions are answered.
Randomization takes place by the randomization program ALEA. It was not possible to blind
investigator, patient, physician or nurse.
Patient groups consist of an intervention group (51 patients) and a control group (51
patients). The intervention group receives postoperatively during 5 consecutive days
hand-foot massage from volunteers who are trained by a professional. It was not possible to
receive massage in the weekends because of the absence of the volunteers. The technique
comprised standard 'Swedish' massage, which means applying kneading and strokes to soft
tissues and muscles. The intervention was performed by applying ethereal oils from Volatile,
which consisted of 10% jojoba and 90% almond oil.
The control group receives the usual care.
Patients from both groups are asked to fill in questionnaires about health status/health
related quality of life (EQ-5D-3L) and anxiety/depression (HADS-NL) at specific moments in
time. Those include one week pre-operatively (baseline), post-operative day (POD) 1, POD3,
POD5 and when they return at the policlinic after hospital's discharge. Before discharge,
every patient is asked to fill in a questionnaire about patient satisfaction concerning the
received hospital care as well.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Not yet recruiting |
NCT05044312 -
Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis
|
N/A | |
Active, not recruiting |
NCT05053191 -
Advancing Nursing Practices in Hospital Oncology Care
|
N/A | |
Completed |
NCT03611309 -
Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members
|
N/A | |
Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06398314 -
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
|
N/A | |
Withdrawn |
NCT04030624 -
Remote Electronic Patient Monitoring in Gastrointestinal Cancer
|
N/A | |
Completed |
NCT02222259 -
A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients
|
N/A | |
Completed |
NCT02140593 -
The Laparotomy Study
|
Phase 4 | |
Active, not recruiting |
NCT00716209 -
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
|
N/A | |
Recruiting |
NCT01484444 -
Biomarker Analysis of Gastrointestinal Cancer
|
N/A | |
Completed |
NCT02130427 -
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
|
N/A | |
Active, not recruiting |
NCT00710632 -
Screening to Predict Weight Loss in Patients With Cancer
|
N/A | |
Completed |
NCT00094965 -
Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function
|
Phase 2 | |
Terminated |
NCT04077372 -
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
|
N/A | |
Recruiting |
NCT04899908 -
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
|
Phase 2 | |
Recruiting |
NCT05429866 -
Immunological Variables Associated to ICI Toxicity in Cancer Patients
|
Phase 2 | |
Recruiting |
NCT05226221 -
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
|
||
Recruiting |
NCT03286348 -
Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer
|
N/A |